Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. A portable, light-weight, gaspowered, cooling device (PLCD, Portable Limb Cooling Device) for prolonged field damage control of injured ischemic limbs

    SBC: Moveo Walks, Inc.            Topic: DHA182003

    We hypothesize that a combination of advanced insulating fabrics and a cooling method (gas-operated) can be integrated into a portable, light-weight device for field/en route controlled limb cooling.We aim to fabricate a prototype portable device for limb cooling, test its efficacy, and optimize its in preparation of large animal and human trials.The cooling device will consist of a mechanism for ...

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  2. Advanced Manufacturing and Material Measurements Software Tool Weave ™ for the Acceleration and Automation of SEM Image Analysis in the Semiconductor Industry

    SBC: Sandbox Semiconductor Incorporated            Topic: None

    In this Phase I SBIR proposal, SandBox Semiconductor™ proposes to develop an Advanced Manufacturing and Material Measurements software tool called Weave ™ for accelerating and automating SEM image analysis for the semiconductor industry. During the development of a new manufacturing process line for a semiconductor device, tens of thousands of scanning electron microscopy (SEM) images are take ...

    SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology
  3. Automated Vascular Access in Trauma Patients

    SBC: Triton Systems, Inc.            Topic: DHA173003

    A portable point of care device is proposed with features to enable rapid, automated, vascular access with single-stick accuracy by a medic with limited experience.A user-friendly GUI guides the medic in the devices use. Novel proprietary algorithms are employed to recognize key anatomical features and to determine an optimal vascular access site even with poor quality images.A miniature camera-ba ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  4. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: Zymeron Corporation            Topic: CBD181004

    Given the unforeseen/unanticipated use of nerve agents in the battlefield and on the homeland, military personnel can benefit from this oncedaily pretreatment. It may also be desirable to pretreat certain medical and emergency aid personnel following a known/suspected nerveagent attack. Also, a novel, improved PB extended release formulations can be commercialized for the treatment of myasthenia g ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  5. Clinical Decision Support for Dermatology Diagnosis in No-Communications Theater Environments

    SBC: 3Derm Systems, Inc.            Topic: DHA182001

    This proposal will investigate the requirements for an automated system that can provide triage, treatment, and diagnostic support for skin infections and other non-domestic dermatological conditions military personnel are at risk of contracting. 3Derm Systems, Inc. will utilize a patent-pending, color-calibrated 3D skin imager along with a deep understanding of teledermatology and patient/dermato ...

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  6. Compact Speaker Array for Clinical Testing of Ear-level Devices

    SBC: FTL Labs Corporation            Topic: DHA18007

    While clinical audiometry is most often conducted with headphones, there are many practical cases where it is desirable to measure the free-space hearing performance of both normal-hearing listeners and listeners wearing hearing aids, hearing protection devices, or implantable hearing prosthetics, both for evaluating fitness for duty and for evaluating outcomes of clinical interventions. Tradition ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  7. Complex Crystalloid Resuscitative Fluid

    SBC: GanD Inc            Topic: DHA172009

    Problem: Currently available resuscitation fluids have been shown to induce detrimental effects on trauma outcomes.Objective: The objective of this proposal is to use the data from the successful Phase 1 studies to guide the continued development and testing of the novel resuscitation fluid (GND-001), which has been designed to address the deficiencies of current resuscitation fluids.Proposed work ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  8. Developing Silicon Nanowire Sensors to Measuring Host-Cell Proteins at a Biomanufacturing Line

    SBC: Advanced Silicon Group            Topic: None

    Our biosensor is made of silicon nanowire arrays functionalized with antibodies to measure the concentration of specific proteins. In this grant we will take a sensor that has been demonstrated for use in measuring a set of generic host cell proteins and we will apply the sensor to measure a set of proteins for a specific cell line. In doing so, we will demonstrate the utility of our sensor to be ...

    SBIR Phase II 2019 Department of CommerceNational Institute of Standards and Technology
  9. Development of the JoRT Platform for Realistic Joint Reduction Training

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: DHA173002

    Joint reduction is a key skill and is a core competency for orthopedic surgeons deploying as part of a trauma team.Current training options are limited to classroom instruction on uninjured persons due to lack of a suitable training simulator. The first true reduction performed by medical providers is on actual patients. This method of instruction prevents the trainee from developing the comfort a ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  10. Dual Formulation of Atropine and Scopolamine with Enhanced Stability

    SBC: Nano Terra, Inc.            Topic: CBD181005

    The standard US military treatment for nerve agent exposure is application of up to three autoinjectors, each containing atropine sulfate and2-pralidoxime, to counteract symptoms of nerve agent intoxication and restore acetylcholinesterase activity. This treatment increases survivalrates after nerve agent exposure, however, seizures resulting from nerve agent poisoning are a common symptom that ca ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government